Aspirin has been associated with a reduced risk of colorectal cancer and--based on limited evidence--to cancers of the oesophagus, stomach, breast, ovary and lung. The role of aspirin on other cancers, such as pancreatic, prostate and bladder cancer and non-Hodgkin's lymphomas and myeloma is less clear, and an increase of risk has been suggested for kidney cancer. For most cancer sites, however, significant heterogeneity between studies, and particularly between study design, was found, with a reduction in risk generally stronger in case-control studies than in cohort ones.
Aspirin and cancer risk : a summary review to 2007 / C. Bosetti, S. Gallus, C. La Vecchia - In: Cancer Prevention II / [a cura di] H.J. Senn, U. Kapp, F. Otto. - [s.l] : Springer, 2009. - ISBN 9783540692966. - pp. 231-251 (( Intervento presentato al 5. convegno International Cancer Prevention Conference tenutosi a St Gallen (CH) nel 2008.
Aspirin and cancer risk : a summary review to 2007
C. La VecchiaUltimo
2009
Abstract
Aspirin has been associated with a reduced risk of colorectal cancer and--based on limited evidence--to cancers of the oesophagus, stomach, breast, ovary and lung. The role of aspirin on other cancers, such as pancreatic, prostate and bladder cancer and non-Hodgkin's lymphomas and myeloma is less clear, and an increase of risk has been suggested for kidney cancer. For most cancer sites, however, significant heterogeneity between studies, and particularly between study design, was found, with a reduction in risk generally stronger in case-control studies than in cohort ones.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
